US › Healthcare

Xtant Medical Holdings Inc (XTNT)

US · Healthcare · Medical Devices

$0.33+2.19%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$23.0M

Revenue YoY

-35.0%

Net profit

$-9.4M

Profit YoY

-365.2%

EPS

$-0.07

EPS estimate

$-0.02

Net margin

-40.9%

EPS came in at -0.07 against a street estimate of -0.02 — a miss of 250.0%.

Key statistics

Market cap

$44.9M

Forward P/E

34.8

P/B

1.12

Book value

$0.28

EPS (TTM)

$-0.08

52-week high

$0.95

52-week low

$0.27

50-day MA

$0.39

200-day MA

$0.52

Beta

-0.15

Analyst view

Analysts rate Xtant Medical Holdings Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $1.03.

Shareholding

Insiders

15.65%

Institutions

56.94%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Xtant Medical Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.